| Dr John Howard Litts Jr, DC | |
|
15 Huntington Plz, Shelton, CT 06484-5211 | |
| (203) 926-9841 | |
| (203) 926-1681 |
| Full Name | Dr John Howard Litts Jr |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 28 Years |
| Location | 15 Huntington Plz, Shelton, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093895070 | NPI | - | NPPES |
| C02311 | Other | CT | GROUP IDENTIFIER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 001258 (Connecticut) | Primary |
| Provider Name | Huntington Chiropractic Center, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1033312517 PECOS PAC ID: 2961669668 Enrollment ID: O20120208000498 |
News Archive
While emergency efforts bring immediate relief to Haiti, Craig Juntunen, founder of Chances for Children, launched the "Haiti Renewal Fund" January 19. The fund, designed to assist in a fresh renewal of the devastated nation of Haiti, opens with an initial matching grant of $2 million from Jackson Hole residents Lynn and Foster Friess augmented by a subsequent $1 million from Childhelp, drawn from donations specifically designated to the fund.
"As Congress's debate over health-care legislation lumbers toward a defining test for the Obama presidency, partisans on both sides of another issue - immigration - escalated their own proxy war this week, concluding that the fates of the two issues have become politically linked" (Hsu, 9/15).
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
The high burden of disease caused by the COVID-19 pandemic has led to much research on effective ways to mitigate the health, social, and economic impact of the spread of the infection. A recent study published on the preprint server bioRxiv* in September 2020 reports on the characteristics of the drug baricitinib when used as monotherapy to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Howard Litts Jr, DC 1 Trap Falls Rd, Ste 1101, Shelton, CT 06484-7601 Ph: (203) 926-9841 | Dr John Howard Litts Jr, DC 15 Huntington Plz, Shelton, CT 06484-5211 Ph: (203) 926-9841 |
News Archive
While emergency efforts bring immediate relief to Haiti, Craig Juntunen, founder of Chances for Children, launched the "Haiti Renewal Fund" January 19. The fund, designed to assist in a fresh renewal of the devastated nation of Haiti, opens with an initial matching grant of $2 million from Jackson Hole residents Lynn and Foster Friess augmented by a subsequent $1 million from Childhelp, drawn from donations specifically designated to the fund.
"As Congress's debate over health-care legislation lumbers toward a defining test for the Obama presidency, partisans on both sides of another issue - immigration - escalated their own proxy war this week, concluding that the fates of the two issues have become politically linked" (Hsu, 9/15).
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
The high burden of disease caused by the COVID-19 pandemic has led to much research on effective ways to mitigate the health, social, and economic impact of the spread of the infection. A recent study published on the preprint server bioRxiv* in September 2020 reports on the characteristics of the drug baricitinib when used as monotherapy to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
› Verified 6 days ago
Connecticut Orthopaedics Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 330 Bridgeport Ave, Shelton, CT 06484 Phone: 203-538-0020 Fax: 203-538-0023 | |
Huntington Chiropractic Center, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 15 Huntington Plz, Shelton, CT 06484 Phone: 203-926-9841 Fax: 203-926-1681 | |
Connecticut Orthopaedic Specialists, Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 100 Beard Sawmill Rd, Shelton, CT 06484 Phone: 203-445-5550 Fax: 203-452-3099 | |
Dr. Edward A Dessau, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 45 White St, Shelton, CT 06484 Phone: 203-924-7557 Fax: 203-924-1112 | |
Dr. Charles W Benson, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 100 Beard Sawmill Rd Unit 115, Shelton, CT 06484 Phone: 203-695-3243 | |
Dr. Annette C Sandt, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1077 Bridgeport Ave, Shelton, CT 06484 Phone: 203-929-5700 Fax: 203-929-5600 |